Ribociclib-endocrine Combination Therapy Versus Chemotherapy as 1st Line in Visceral mBC
Clinical trial NCT03905343 · TERMINATED
Trial details
- NCT number
- NCT03905343
- Sponsor
- Swiss Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-25
- Primary completion
- 2021-04-15
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.